1-231040168-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_198552.3(FAM89A):c.44C>T(p.Ala15Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000674 in 1,186,856 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_198552.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM89A | NM_198552.3 | c.44C>T | p.Ala15Val | missense_variant | 1/2 | ENST00000366654.5 | NP_940954.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM89A | ENST00000366654.5 | c.44C>T | p.Ala15Val | missense_variant | 1/2 | 1 | NM_198552.3 | ENSP00000355614.4 |
Frequencies
GnomAD3 genomes AF: 0.0000271 AC: 4AN: 147490Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000385 AC: 4AN: 1039366Hom.: 0 Cov.: 31 AF XY: 0.00000202 AC XY: 1AN XY: 494674
GnomAD4 genome AF: 0.0000271 AC: 4AN: 147490Hom.: 0 Cov.: 32 AF XY: 0.0000418 AC XY: 3AN XY: 71856
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 20, 2024 | The c.44C>T (p.A15V) alteration is located in exon 1 (coding exon 1) of the FAM89A gene. This alteration results from a C to T substitution at nucleotide position 44, causing the alanine (A) at amino acid position 15 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at